Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,934,898 papers from all fields of science
Search
Sign In
Create Free Account
SU014813
An orally-active, tyrosine kinase receptor inhibitor with potential antitumor activity. SU014813 binds to and inhibits the phosphorylation of…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
FLT1 protein, human
FLT3 protein, human
Mast/Stem Cell Growth Factor Receptor Kit, human
Platelet-Derived Growth Factor Receptor
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Untersuchung der möglichen Rolle von zirkulierenden vaskulären und lymphatischen Endothelzellen, sowie zirkulierenden Tumorzellen im Blut als Surrogatmarker für die klinische Wirkung bei der…
Hubertus Wald Tumorzentrum
,
C. Bokemeyer
2009
Corpus ID: 85909099
2008
2008
Phase I safety and pharmacokinetic (PK) study of SU014813 (S) in combination with docetaxel (D) in patients (pts) with solid tumors (STs)
P. Schöffski
,
M. D. de Jonge
,
+4 authors
J. Verweij
2008
Corpus ID: 74519423
3554 Background: S is an oral, multitargeted tyrosine kinase inhibitor (TKI) of PDGFRs, VEGFR-1 and -2, KIT and FLT3. This phase…
Expand